C92.32

Billable

Myeloid sarcoma, in relapse

C92.32 is the ICD-10-CM code for Myeloid sarcoma, in relapse. It is a billable, specific code valid for reimbursement.

Status
Billable
Chapter
C00-D49
Parent
C92.3
Edition
FY2026

C00-D49 Neoplasms

What this means — in plain language

MedlinePlus · NIH

What is leukemia? Leukemia is a term for cancers of the blood cells. Leukemia starts in blood-forming tissues such as the bone marrow. Your bone marrow makes the cells which will develop into white blood cells, red blood cells, and platelets. Each type of cell has a different job: White blood cells help your body fight infection Red blood cells deliver oxygen from your lungs to your tissues and organs Platelets help…

Read more about Leukemia at MedlinePlus ↗

Source: U.S. National Library of Medicine (MedlinePlus). Informational only — not medical advice.

No additional coding notes for this code.

Medications indicated for this condition

FDA labeling

Drugs whose FDA labeling lists this condition's category among its indications. Informational only — not a treatment recommendation or medical advice.

Conditions mapped to this code

MedlinePlus · NIH

Plain-language health-topic references grounded in MedlinePlus (NIH/NLM).

Frequently asked questions

What is ICD-10 code C92.32?
C92.32 is the ICD-10-CM code for "Myeloid sarcoma, in relapse". It falls under C00-D49 Neoplasms.
Is C92.32 a billable code?
Yes — C92.32 is a billable, specific ICD-10-CM code valid for reimbursement.

Source: CMS ICD-10-CM FY2026. For informational purposes only — not medical advice. See our medical disclaimer.

Look up another ICD-10 code or condition

Powered by Eleplan

Free ICD-10 lookup is just the start. Eleplan keeps the whole care plan in one place.

Diagnoses, medications, documents, appointments, and the whole care team — organized and always in sync, with Ellie, your AI care assistant, on top of it. Free to start.